https://www.selleckchem.com/pr....oducts/blasticidin-s
0001). Study group patients incurred significantly higher 90-day episode-of-care costs ($15,124.55 vs. $14,610.01, p less then 0.0001). Additionally, Paget's disease patients were found to have higher incidences and odds of medical/surgical (25.93 vs. 13.58%; OR 1.64, p less then 0.0001) and implant-related complications (8.97 vs. 5.02%; OR 1.71, p less then 0.0001). Specifically, Paget's disease patients were more likely to have periprosthetic fractures, mechanical loosening, and revision TKAs (p less then 0.0001). Th
Like
Comment
Share
